Journal article
Diphosphonates in Paget's disease.
- Abstract:
-
The diphosphonate, sodium etidronate (disodium ethane-1-hydroxy-1,1-diphosphonate) (E.H.D.P.), which inhibits the growth and dissolution of calcium phosphate crystals in vitro, was given at doses of 0, 1, 5, 10, or 20 mg. per kg. per day for up to 6 months to forty-seven patients with Paget's disease of bone. There was a dose-related suppression of the raised alkaline phosphatase in plasma and total hydroxyproline in urine, and at 20 mg. per kg. per day nearly half of the patients had normal ...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Lancet
- Volume:
- 1
- Issue:
- 7863
- Pages:
- 894-898
- Publication date:
- 1974-05-01
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
- Source identifiers:
-
108973
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:108973
- UUID:
-
uuid:34878263-798b-484b-884f-49eaec242704
- Local pid:
- pubs:108973
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 1974
If you are the owner of this record, you can report an update to it here: Report update to this record